Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/6037
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDiLeo, A.-
dc.contributor.authorBUYSE, Marc-
dc.date.accessioned2007-12-20T16:04:23Z-
dc.date.available2007-12-20T16:04:23Z-
dc.date.issued2002-
dc.identifier.citationJournal of clinical oncology, 20(7). p. 1954-1955-
dc.identifier.issn0732-183X-
dc.identifier.urihttp://hdl.handle.net/1942/6037-
dc.language.isoen-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.titleEquivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer-
dc.typeJournal Contribution-
dc.identifier.epage1955-
dc.identifier.issue7-
dc.identifier.spage1954-
dc.identifier.volume20-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.isi000174845200040-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
item.fullcitationDiLeo, A. & BUYSE, Marc (2002) Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer. In: Journal of clinical oncology, 20(7). p. 1954-1955.-
item.contributorDiLeo, A.-
item.contributorBUYSE, Marc-
crisitem.journal.issn0732-183X-
crisitem.journal.eissn1527-7755-
Appears in Collections:Research publications
Show simple item record

WEB OF SCIENCETM
Citations

6
checked on May 10, 2024

Page view(s)

60
checked on May 23, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.